BRNS
NASDAQ
GB
Barinthus Biotherapeutics plc - American Depositary Shares
$0.60
▲ +$0.06
(+11.11%)
Vol 19K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$28.6M
ROE
-49.8%
Margin
-54.2%
D/E
0.00
Beta
-0.69
52W
$1–$3
Wall Street Consensus
8 analysts · Apr 20262
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 40.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.35 | $-0.27 | +$0.08 |
| Sep 2025 | $-0.40 | $-0.24 | +$0.16 |
| Jun 2025 | $-0.34 | $-0.52 | $-0.18 |
| Mar 2025 | $-0.34 | $-0.49 | $-0.15 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $15.0M | — | — | — | — |
| Net Income | -$8.1M | -$20.5M | -$19.6M | -$21.1M | -$14.6M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -46.5% | -46.5% | -46.5% | -49.8% | -49.8% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -54.2% | -54.2% | -54.2% | -54.2% | -54.2% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 7.89 | 9.18 | 7.89 | 7.89 | 8.04 | 8.04 |
Key Ratios
ROA (TTM)
-39.9%
P/S (TTM)
1.91
P/B
0.4
EPS (TTM)
$-1.36
CF/Share
$-1.89
Rev Growth 3Y
+282.3%
52W High
$2.92
52W Low
$0.64
$0.64
52-Week Range
$2.92
Financial Health
Free Cash Flow
-$10.7M
Net Debt
-$62.7M
Cash
$74.3M
Total Debt
$11.6M
As of Sep 30, 2025
How does BRNS compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
BRNS valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
1.9
▼
85%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
0.4
▼
85%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
BRNS profitability vs Biotechnology peers
ROE
-49.8%
▲
26%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-54.2%
▲
81%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-39.9%
▲
15%
above
peers
(-46.7%)
vs Peers
vs Industry
In line
BRNS financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
8.0
▲
81%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
-0.7
▼
171%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
BRNS fundamentals radar
BRNS
Peer median
Industry
BRNS profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
BRNS vs peers: key metrics
Top Holders
Top 5: 18.43%M&G Plc
12.73%
$2.9M
HSG Holding Ltd
3.48%
$781K
DC Funds, LP
1.57%
$353K
Renaissance Technologies, L…
0.35%
$79K
Johns Hopkins University
0.30%
$67K
As of Dec 31, 2025
Latest News
No related news yet